Survival Analysis of 1140 Patients with Biliary Cancer and Benefit from Concurrent Renin-Angiotensin Antagonists, Statins, or Aspirin with Systemic Therapy

por Gunchick, Valerie, McDevitt, Rachel L, Choi, Elizabeth, Winslow, Katherine, Zalupski, Mark M, Sahai, Vaibhav
Publicado 2023

DEPTOR has growth suppression activity against pancreatic cancer cells

por Li, Hua, Sun, Grace Y., Zhao, Yongchao, Thomas, Dafydd, Greenson, Joel K., Zalupski, Mark M., Ben-Josef, Edgar, Sun, Yi
Publicado 2014

SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy

por Davis, Elizabeth J., Zhao, Lili, Lucas, David R., Schuetze, Scott M., Baker, Laurence H., Zalupski, Mark M., Thomas, Dafydd, Chugh, Rashmi
Publicado 2016

A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT‐01

por Sahai, Vaibhav, Griffith, Kent A., Beg, Muhammad S., Shaib, Walid L., Mahalingam, Devalingam, Zhen, David B., Deming, Dustin A., Zalupski, Mark M.
Publicado 2022

Screening for Depression, Sleep-Related Disturbances, and Anxiety in Patients with Adenocarcinoma of the Pancreas: A Preliminary Study

por Boyd, Andrew D., Brown, Doris, Henrickson, Chris, Hampton, Janet, Zhu, Bin, Almani, Farideh, Ben-Josef, Edgar, Zalupski, Mark, Simeone, Diane M., Taylor, Jeremy M. G., Armitage, Roseanne, Riba, Michelle
Publicado 2012

Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer

por Chatterjee, Moumita, Ben-Josef, Edgar, Thomas, Dafydd G., Morgan, Meredith A., Zalupski, Mark M., Khan, Gazala, Andrew Robinson, Charles, Griffith, Kent A., Chen, Ching-Shih, Ludwig, Thomas, Bekaii-Saab, Tanios, Chakravarti, Arnab, Williams, Terence M.
Publicado 2015

Genomics driven precision oncology in advanced biliary tract cancer improves survival

por Kumar-Sinha, Chandan, Vats, Pankaj, Tran, Nguyen, Robinson, Dan R., Gunchick, Valerie, Wu, Yi-Mi, Cao, Xuhong, Ning, Yu, Wang, Rui, Rabban, Erica, Bell, Janice, Shankar, Sunita, Mannan, Rahul, Zhang, Yuping, Zalupski, Mark M., Chinnaiyan, Arul M., Sahai, Vaibhav
Publicado 2023

Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data

por Giovinazzo, Francesco, Soggiu, Fiammetta, Jang, Jin-Young, Versteijne, Eva, van Tienhoven, Geertjan, van Eijck, Casper H., Han, Youngmin, Choi, Seong Ho, Kang, Chang Moo, Zalupski, Mark, Ahmad, Hasham, Yentz, Sarah, Helton, Scott, Rose, J. Bart, Takishita, Chie, Nagakawa, Yuichi, Abu Hilal, Mohammad
Publicado 2020

A Pilot Study of Diffusion-Weighted MRI in Patients Undergoing Neoadjuvant Chemoradiation for Pancreatic Cancer

por Cuneo, Kyle C., Chenevert, Thomas L., Ben-Josef, Edgar, Feng, Mary U., Greenson, Joel K., Hussain, Hero K., Simeone, Diane M., Schipper, Matthew J., Anderson, Michelle A., Zalupski, Mark M., Al-Hawary, Mahmoud, Galban, Craig J., Rehemtulla, Alnawaz, Feng, Felix Y., Lawrence, Theodore S., Ross, Brian D.
Publicado 2014

Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials

por Ledenko, Matthew, Antwi, Samuel O., Arima, Shiho, Driscoll, Julia, Furuse, Junji, Klümpen, Heinz-Josef, Larsen, Finn Ole, Lau, David K., Maderer, Annett, Markussen, Alice, Moehler, Markus, Nooijen, Lynn E., Shaib, Walid L., Tebbutt, Niall C., André, Thierry, Ueno, Makoto, Woodford, Rachel, Yoo, Changhoon, Zalupski, Mark M., Patel, Tushar
Publicado 2022

A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor

por Bendell, Johanna C, Javle, Milind, Bekaii-Saab, Tanios S, Finn, Richard S, Wainberg, Zev A, Laheru, Daniel A, Weekes, Colin D, Tan, Benjamin R, Khan, Gazala N, Zalupski, Mark M, Infante, Jeffrey R, Jones, Suzanne, Papadopoulos, Kyriakos P, Tolcher, Anthony W, Chavira, Renae E, Christy-Bittel, Janna L, Barrett, Emma, Patnaik, Amita
Publicado 2017

Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors

por Cobain, Erin F., Wu, Yi-Mi, Vats, Pankaj, Chugh, Rashmi, Worden, Francis, Smith, David C., Schuetze, Scott M., Zalupski, Mark M., Sahai, Vaibhav, Alva, Ajjai, Schott, Anne F., Caram, Megan E. V., Hayes, Daniel F., Stoffel, Elena M., Jacobs, Michelle F., Kumar-Sinha, Chandan, Cao, Xuhong, Wang, Rui, Lucas, David, Ning, Yu, Rabban, Erica, Bell, Janice, Camelo-Piragua, Sandra, Udager, Aaron M., Cieslik, Marcin, Lonigro, Robert J., Kunju, Lakshmi P., Robinson, Dan R., Talpaz, Moshe, Chinnaiyan, Arul M.
Publicado 2021

Integrative Clinical Genomics of Metastatic Cancer

por Robinson, Dan R., Wu, Yi-Mi, Lonigro, Robert J., Vats, Pankaj, Cobain, Erin, Everett, Jessica, Cao, Xuhong, Rabban, Erica, Kumar-Sinha, Chandan, Raymond, Victoria, Schuetze, Scott, Alva, Ajjai, Siddiqui, Javed, Chugh, Rashmi, Worden, Francis, Zalupski, Mark M., Innis, Jeffrey, Mody, Rajen J., Tomlins, Scott A., Lucas, David, Baker, Laurence H., Ramnath, Nithya, Schott, Ann F., Hayes, Daniel F., Vijai, Joseph, Offit, Kenneth, Stoffel, Elena M., Roberts, J. Scott, Smith, David C., Kunju, Lakshmi P., Talpaz, Moshe, Cieslik, Marcin, Chinnaiyan, Arul M.
Publicado 2017